19th Sep 2013 07:54
LONDON (Alliance News) - Oxford BioMedica PLC said Thursday that Andrew Heath, a non-executive director, purchased 100,000 shares at 2.58 pence apiece on Wednesday.
Following the purchase, Heath holds 600,000 shares in the gene-based biopharmaceutical company.
In early trading Thursday, Oxford BioMedica shares were quoted at 2.58p, down 0.01p.
By Tom Waite; [email protected]; @thomaslwaite
Copyright 2013 Alliance News Limited. All Rights Reserved.
Related Shares:
Oxford Biomedica